Clinical

Clinical  ·  Weekly Digest 11
PDS Biotechnology reported promising interim data of the PDS0101 and Pembrolizumab combo in HNSCC

Weekly Digest – 20-26 May 2023 Weekly Digest – 20-26 May 2023 May 25, 2023: PDS0101 (SC) / Pembrolizumab (IV) / Head and Neck Cancer / PDS Biotechnology: Encouraging data from Phase 2 VERSATILE-002 study  PDS Biotechnology reported encouraging data […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 11
Mirati Therapeutics’ SAPPHIRE study evaluating Sitravatinib + Opdivo missed the primary endpoint in NSCLC

Weekly Digest – 20-26 May 2023 Weekly Digest – 20-26 May 2023 May 24, 2023: Sitravatinib (IV) / Nivolumab (Opdivo) (IV) / NSCLC / Mirati Therapeutics: Phase 3 SAPPHIRE study did not meet the primary endpoint of overall survival The […]

by Sandhya Ramalingam

Continue Reading